Position in NTRA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$399
New position
Shares Held
2
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Frazier Financial Advisors, LLC holds $165,444 across 9 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
106 | $53,144 | |
| 2 | DGX |
Quest Diagnostics Inc
|
166 | $35,183 | |
| 3 | LH |
Labcorp Holdings Inc.
|
100 | $28,000 | |
| 4 | DHR |
Danaher Corp /De/
|
121 | $23,048 | |
| 5 | WAT |
Waters Corp /De/
|
30 | $11,251 | |
| 6 | A |
Agilent Technologies, Inc.
|
59 | $7,836 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
10 | $5,264 | |
| 8 | BLLN |
BillionToOne, Inc.
|
14 | $1,679 |
All Filings in NTRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $399 | 2 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||